Featured Research

from universities, journals, and other organizations

Knowledge about incontinence, pelvic organ prolapse lower among women of color

Date:
October 29, 2013
Source:
Yale University
Summary:
Knowing what symptoms to look for may help women with pelvic floor disorders improve their chances of successful treatment. But knowledge of these disorders is lacking among most women, and especially among women of color, according to a new study.

Knowing what symptoms to look for may help women with pelvic floor disorders improve their chances of successful treatment. But knowledge of these disorders is lacking among most women, and especially among women of color, according to a new study by researchers at Yale School of Medicine.

The study appears in the October issue of the American Journal of Obstetrics and Gynecology.

Insufficient knowledge and misconceptions about pelvic floor disorders, which include urinary incontinence, fecal incontinence, and pelvic organ prolapse, are thought to be one of the biggest barriers to seeking care. "If we can improve knowledge about pelvic floor disorders, we may be able to improve outcomes for all women," said corresponding author Marsha K. Guess, M.D.

Pelvic floor disorders are a major public health concern, Guess said, noting that about 25% of women 20 years or older in the United States suffer from at least one of the three most prevalent pelvic floor disorders: urinary incontinence, fecal incontinence, and pelvic organ prolapse. Recent epidemiologic studies project that the number of women with these disorders will increase significantly over the next 40 years. The United States spends over $12 billion annually for the management and treatment of urinary incontinence alone, and this number is also expected to rise in the coming years.

Guess and her colleagues conducted a cross-sectional study of 431 women of all ages, races, and socioeconomic levels. They found that over 71% of these women lacked knowledge about urinary incontinence, and 48% lacked knowledge about pelvic organ prolapse. After adjusting for age, race, household income, and education, the researchers determined that African-American women and the combined group of Hispanic, Asian and other non-white women were significantly less knowledgeable about these conditions than their white counterparts.

"Improving knowledge about health problems has proven effective in promoting behavioral change, reducing levels of disease symptoms, and improving compliance with treatment for other chronic diseases," said Charisse Mandimika, a Yale School of Medicine student who was the study's first author. "This study shows that African-American women and non-white groups in general are not benefiting from this knowledge."

The study also found that women with a history of pelvic organ prolapse demonstrated greater knowledge than women who had not had this problem, but women with a history of urinary incontinence did not have more knowledge of the disorder than their unaffected counterparts.

"Another very concerning finding is that the majority of women who experienced urinary incontinence had not received treatment," said Guess. "Culturally sensitive educational interventions are urgently needed to raise awareness, and address these disparities in knowledge head on.


Story Source:

The above story is based on materials provided by Yale University. Note: Materials may be edited for content and length.


Journal Reference:

  1. Charisse L. Mandimika, William Murk, Alexandra Mcpencow, AeuMuro Lake, Terri Wedderburn, Charlene Collier, Kathleen A. Connell, Marsha K. Guess. Knowledge of pelvic floor disorders in a population of community-dwelling women. American Journal of Obstetrics and Gynecology, 2013; DOI: 10.1016/j.ajog.2013.10.011

Cite This Page:

Yale University. "Knowledge about incontinence, pelvic organ prolapse lower among women of color." ScienceDaily. ScienceDaily, 29 October 2013. <www.sciencedaily.com/releases/2013/10/131029171954.htm>.
Yale University. (2013, October 29). Knowledge about incontinence, pelvic organ prolapse lower among women of color. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2013/10/131029171954.htm
Yale University. "Knowledge about incontinence, pelvic organ prolapse lower among women of color." ScienceDaily. www.sciencedaily.com/releases/2013/10/131029171954.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins